HHM Wealth Advisors
ABBV icon

HHM Wealth Advisors’s AbbVie ABBV Stock Holding History

HHM Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.46M Sell
9,394
-27
-0.3% -$6.92K 0.23% 36
2026
Q2 		$2.37M Buy
9,421
+36
+0.4% +$7.74K 0.24% 38
2026
Q1 		$2.04M Buy
9,385
+554
+6% +$123K 0.23% 39
2025
Q4 		$2.02M Sell
8,831
-50
-0.6% -$11.4K 0.24% 43
2025
Q3 		$2.06M Buy
8,881
+67
+0.8% +$13.6K 0.24% 38
2025
Q2 		$1.64M Sell
8,814
-219
-2% -$40.7K 0.19% 51
2025
Q1 		$1.89M Buy
9,033
+6
+0.1% +$1.17K 0.25% 42
2024
Q4 		$1.6M Buy
9,027
+3,058
+51% +$562K 0.22% 50
2024
Q3 		$1.18M Sell
5,969
-5
-0.1% -$933 0.17% 55
2024
Q2 		$1.02M Buy
5,974
+1,717
+40% +$284K 0.15% 60
2024
Q1 		$775K Hold
4,257
– – 0.13% 59
2023
Q4 		$660K Buy
4,257
+370
+10% +$53.9K 0.11% 63
2023
Q3 		$579K Buy
3,887
+200
+5% +$29.4K 0.11% 64
2023
Q2 		$497K Hold
3,687
– – 0.09% 75
2023
Q1 		$588K Hold
3,687
– – 0.12% 63
2022
Q4 		$596K Sell
3,687
-10
-0.3% -$1.53K 0.14% 60
2022
Q3 		$496K Sell
3,697
-1,544
-29% -$222K 0.13% 57
2022
Q2 		$803K Sell
5,241
-139
-3% -$21.2K 0.21% 41
2022
Q1 		$872K Buy
5,380
+1,502
+39% +$218K 0.2% 41
2021
Q4 		$525K Buy
3,878
+64
+2% +$7.56K 0.13% 66
2021
Q3 		$411K Buy
3,814
+638
+20% +$72.9K 0.11% 74
2021
Q2 		$358K Hold
3,176
– – 0.1% 82
2021
Q1 		$344K Buy
3,176
+344
+12% +$36.8K 0.11% 75
2020
Q4 		$303K Hold
2,832
– – 0.1% 74
2020
Q3 		$248K Hold
2,832
– – 0.1% 75
2020
Q2 		$278K Sell
2,832
-251
-8% -$22.1K 0.12% 67
2020
Q1 		$235K Buy
3,083
+600
+24% +$51.1K 0.11% 68
2019
Q4 		$220K Buy
+2,483
New +$206K 0.11% 77

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

HHM Wealth Advisors's ABBV Position: Q3 2026 in Review

HHM Wealth Advisors reduced its AbbVie (ABBV) stake by 0.29% in Q3 2026, selling an estimated $6.92K and leaving 9,394 shares worth $2.46M. The position accounts for 0.23% of the portfolio, ranked #36.

HHM Wealth Advisors first reported a position in ABBV in Q4 2019 and has held it in 28 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • HHM Wealth Advisors held 9,394 shares of AbbVie worth $2.46M as of Q3 2026.
  • HHM Wealth Advisors sold 27 AbbVie shares in Q3 2026, an estimated $6.92K.
  • AbbVie made up 0.23% of HHM Wealth Advisors's portfolio in Q3 2026, its #36 holding.
  • HHM Wealth Advisors first reported a position in AbbVie in Q4 2019 and has held it in 28 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on HHM Wealth Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.